Evidence map›Paper›PMID 42445851›Full record

ArticleFrontiers in cellular and infection microbiology2026

Discovery of a new fibronectin-binding surface protein of

Miriam Katsburg, Anna Kopenhagen, Etienne Aubry, Mathias Müsken, Gloria Riebesell, Deborah Simmert, Sanja Haake, Inga Eichhorn, Silver A Wolf, Simone Bergmann and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miriam Katsburg *Institute of Microbiology and Epizootics, Centre for Infection Medicine, Freie Universität Berlin, Berlin, Germany.
Anna Kopenhagen *Institute of Microbiology, Technische Universität Braunschweig, Braunschweig, Germany.
Etienne AubryInstitute of Microbiology and Epizootics, Centre for Infection Medicine, Freie Universität Berlin, Berlin, Germany.
Mathias MüskenCentral Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Gloria RiebesellInstitute of Microbiology, Technische Universität Braunschweig, Braunschweig, Germany.
Deborah SimmertInstitute of Microbiology, Technische Universität Braunschweig, Braunschweig, Germany.
Sanja HaakeInstitute of Microbiology, Technische Universität Braunschweig, Braunschweig, Germany.
Inga EichhornGenome Competence Centre (MF1), Robert Koch Institute (RKI), Berlin, Germany.
Silver A WolfGenome Competence Centre (MF1), Robert Koch Institute (RKI), Berlin, Germany.
Simone Bergmann *Institute of Microbiology, Technische Universität Braunschweig, Braunschweig, Germany.
Marcus Fulde *Institute of Microbiology and Epizootics, Centre for Infection Medicine, Freie Universität Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infective endocarditis is a rare but severe disease in humans and dogs which can be caused by

Indexed as

Adhesins, BacterialFibronectinsStreptococcusAnimalsBacterial AdhesionDNA Transposable ElementsDogsEndocarditis, BacterialEndothelial CellsHumansMutagenesis, InsertionalStreptococcal InfectionsAdhesins, BacterialDNA Transposable Elementsfibronectin-binding proteins, bacterialFibronectinsendothelial infectionendothelial wound healingfibronectinhigh-throughput screeninginfective endocarditisserum opacificationstreptococcal adhesinTRADIS

Identifiers

PMID42445851
PMCPMC13357522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.